This enhancement introduces the Breast Cancer Risk Assessment (BCRAT) form within the 10G Assessments module. Users can now perform standardized breast cancer risk assessments directly within CureMD, calculate 5-year and lifetime risk, and retain the assessment inputs and calculated results as part of the patient's clinical documentation.
This enhancement improves patient safety by making active allergy information readily visible across key Chemotherapy Manager workflows. Active allergies are now displayed in Chemo Plan Reports, Drug Administration Reports, Administration Notes, and the Patient Banner, allowing clinicians to review important allergy information without navigating to other areas of the patient chart.
Posted On: Aug 18, 2026
Posted On: Aug 18, 2026
Posted On: Aug 18, 2026
Posted On: Aug 18, 2026
Posted On: Aug 18, 2026
Posted On: Aug 18, 2026